JPRN-UMIN000019458已完成2 期
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426) - Phase 2 study of Carboplatin plus nab-Paclitaxel for PS 2 advanced NSCLC (TORG1426)
PO Thoracic Oncology Research Group0 个研究点目标入组 42 人开始时间: 2015年10月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with serious infection and/or serious complications(gastrointestinal bleeding, or cardiac disorder, etc) 2) Patients with interstitial pneumonia (by Chest X-P) 3) Patients with prior radiotherapy to primary and /or target region. 4) Patient who is with contraindications to paclitaxel or carboplatin. 5) History of hypersensitivity for albumin products 6) History of poorly controlled pleural effusion,pericardial effusion and ascites 7) Patients with severe renal dysfunction 8) Patients with symptomatic brain metastases 9) Patients with active double cancer less than 5 years disease free period 10) History of Bone-marrow transplantation 11) History of Peripheral blood stem cell transplantation(PBSCT) 12) Patients who declined contraception. 13) Patients with uncontrollable diabetes or hypertension 14) Patients with hepatic cirrhosis
研究者
相似试验
已完成
2 期
Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung CancerChemotherapy naive non-small cell lung cancerJPRN-UMIN000015144Fukuoka University School of Medicine40
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
招募中
1 期
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
已完成
2 期
A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancerThymic cancerJPRN-UMIN000001358West Japan Oncology Group40
已完成
2 期
Phase2 study of Carboplatin / Nab-paclitaxel + Bevacizumab to non-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussionon-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussion in stage4JPRN-UMIN000013329Osaka Prefectural Medical Center for Respiratory and Allergic diseases20